Clearwater, Florida-based Biostem U.S., Corp. (OTCQB: HAIR) reported this morning that the Pizarro Hair Restoration Clinic in Orlando, Florida is now equipped and ready to begin offering The Biostem Method™ of hair re-growth using the patient’s own adult cells in a minimally invasive, painless procedure.  Dr. Marina Pizarro has treated to female patients using the Biostem procedure, paving the way for a broader roll-out of the technology through affiliate agreements across the country.

Dr. Pizarro, Biostem’s Medical Director and Trainer, is ready to offer onsite training to new Biostem affiliates.

“We are making plans to open affiliate offices in major cities soon, after which we will expand the services to rural and international locations focusing first on Europe and Asia,” commented Biostem president John Satino.

According to the American Academy of Dermatology (AAD), hereditary hair loss is a medical condition that affects about 50 million American men and 30 million American women.

In addition to its hair re-growth technologies, Biostem also intends to train and license selected physicians to provide Regenerative Cellular Therapy treatments to assist the body’s natural approach to healing tendons, ligaments, joints and muscle injuries by using the patient’s own stem cells.

Biostem US Corp. (HAIR) Stock Quote and News:

---

Disclaimer: Neither www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.